S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:MASI

Masimo Stock Forecast, Price & News

$230.21
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$221.39
Now: $230.21
$231.13
50-Day Range
$230.21
MA: $259.38
$275.72
52-Week Range
$143.90
Now: $230.21
$284.86
Volume440,178 shs
Average Volume307,351 shs
Market Capitalization$12.72 billion
P/E Ratio59.79
Dividend YieldN/A
Beta0.87
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Masimo logo

Headlines

Masimo Becomes Oversold (MASI)
March 5, 2021 |  nasdaq.com
Masimo (MASI) Q4 2020 Earnings Call Transcript
February 24, 2021 |  fool.com
Recap: Masimo Q4 Earnings
February 23, 2021 |  finance.yahoo.com
Masimo Q4 2020 Earnings Preview - Seeking Alpha
February 23, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000
Employees2,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$937.84 million
Cash Flow$3.24 per share
Book Value$21.90 per share

Profitability

Net Income$196.22 million

Miscellaneous

Market Cap$12.72 billion
Next Earnings Date4/27/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.57 out of 5 stars

Medical Sector

398th out of 1,972 stocks

Electromedical Equipment Industry

9th out of 61 stocks

Analyst Opinion: 2.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$230.21
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Masimo (NASDAQ:MASI) Frequently Asked Questions

Is Masimo a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo
or view top-rated stocks.

What stocks does MarketBeat like better than Masimo?

Wall Street analysts have given Masimo a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Masimo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, April 27th 2021.
View our earnings forecast for Masimo
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) issued its quarterly earnings data on Monday, February, 22nd. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.12. The medical equipment provider earned $295.10 million during the quarter, compared to the consensus estimate of $287.45 million. Masimo had a trailing twelve-month return on equity of 15.75% and a net margin of 20.30%. The business's revenue was up 19.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 earnings per share.
View Masimo's earnings history
.

How has Masimo's stock price been impacted by COVID-19?

Masimo's stock was trading at $182.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MASI shares have increased by 26.0% and is now trading at $230.21.
View which stocks have been most impacted by COVID-19
.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY21 earnings guidance on Tuesday, February, 23rd. The company provided earnings per share (EPS) guidance of $3.80 for the period, compared to the Thomson Reuters consensus estimate of $3.77. The company issued revenue guidance of $1.2 billion, compared to the consensus revenue estimate of $1.18 billion.

What price target have analysts set for MASI?

7 brokers have issued 12-month target prices for Masimo's shares. Their forecasts range from $201.00 to $310.00. On average, they expect Masimo's share price to reach $262.83 in the next year. This suggests a possible upside of 14.2% from the stock's current price.
View analysts' price targets for Masimo
or view top-rated stocks among Wall Street analysts.

Who are Masimo's key executives?

Masimo's management team includes the following people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 56, Pay $3M)
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 42, Pay $713.37k)
  • Mr. Bilal Muhsin, Chief Operating Officer (Age 40, Pay $892.51k)
  • Dr. Steven J. Barker, Chairman of Scientific Advisory Board, Chief Science Officer & Director (Age 76, Pay $190k)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48, Pay $718.05k)
  • Mr. Anand Sampath, Exec. VP of Operations & Clinical Research (Age 55, Pay $774.84k)
  • Mr. J. Todd Koning, Sr. VP & Chief Accounting Officer (Age 49)
  • Mr. Yongsam Lee, Exec. VP & Chief Information Officer (Age 56)
  • Mr. Eli Kammerman, VP of Bus. Devel. & Investor Relations
  • Mr. Jon Coleman, Pres of Worldwide Sales, Professional Services & Medical Affairs (Age 57)

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

Who are some of Masimo's key competitors?

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), The Trade Desk (TTD), The Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.11%), FMR LLC (6.95%), Ownership Capital B.V. (3.15%), Bank of New York Mellon Corp (1.54%), Victory Capital Management Inc. (0.94%) and Northern Trust Corp (0.91%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo
.

Which institutional investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Victory Capital Management Inc., Wells Fargo & Company MN, Schroder Investment Management Group, Ensemble Capital Management LLC, Strs Ohio, Janus Henderson Group PLC, and Royce & Associates LP. Company insiders that have sold Masimo company stock in the last year include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Thomas Samuel Mcclenahan, and Yongsam Lee.
View insider buying and selling activity for Masimo
or view top insider-selling stocks.

Which institutional investors are buying Masimo stock?

MASI stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, BlackRock Inc., Ownership Capital B.V., Martin Currie Ltd., Morgan Stanley, DF Dent & Co. Inc., Nuveen Asset Management LLC, and State of Michigan Retirement System.
View insider buying and selling activity for Masimo
or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $230.21.

How much money does Masimo make?

Masimo has a market capitalization of $12.72 billion and generates $937.84 million in revenue each year. The medical equipment provider earns $196.22 million in net income (profit) each year or $3.22 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 2,000 workers across the globe.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

Where are Masimo's headquarters?

Masimo is headquartered at 52 DISCOVERY, IRVINE CA, 92618.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]


This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.